Status:
UNKNOWN
Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University of Oslo
Helse Sor-Ost
Conditions:
Adenomyosis
Eligibility:
FEMALE
30-50 years
Brief Summary
Adenomyosis is characterized by the appearance of endometrial cells in the muscular layer of the uterus. It affects about 15-20% of the female population. The symptoms of adenomyosis are heavy menstr...
Detailed Description
Biopsy of focal adenomyosis of the myometrium: This will be an extension of the NAPPED1-study. The investigators will perform ultrasound-guided transvaginal biopsies of the myometrium and collect ven...
Eligibility Criteria
Inclusion
- Premenopausal women aged 30 - 50 years old scheduled for vaginal, abdominal or laparoscopic total hysterectomy one or more of the following clinical symptoms:
- bleeding disorders (menorrhagia, irregular bleeding, hypermenorrhoea),
- chronic pelvic pain,
- dysmenorrhoea,
- or dyspareunia junction zone definable
Exclusion
- postmenopausal women,
- pregnancy
- gynecological cancer
- GnRH analog therapy or systemic hormone therapy in the last three months prior to hysterectomy
- junctional zone not identifiable
Key Trial Info
Start Date :
August 6 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02197923
Start Date
August 6 2014
End Date
December 1 2024
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynecological department, Oslo University Hospital, Ullevål
Oslo, Norway, 0382